{"id":61834,"date":"2025-09-09T04:06:53","date_gmt":"2025-09-09T02:06:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/"},"modified":"2025-09-09T04:06:53","modified_gmt":"2025-09-09T02:06:53","slug":"medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/","title":{"rendered":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor"},"content":{"rendered":"
\n

MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (TSXV: MDX), \u201cMedX<\/b>\u201d or the \u201cCompany<\/b>\u201d), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company.<\/p>\n

<\/a>
<\/a><\/p>\n

\nDr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist and then spent more than three decades in the company\u2019s Research & Development (R&D) divisions, where he applied his expertise to develop breakthrough measures of skin condition, optics and health. Across his 36 year career, he drove serial innovation across some of P&G\u2019s most iconic brands in skin care, colour cosmetics, personal cleansing, hand and body care, and was sought out as a consultant for projects across P&G\u2019s other product categories. He retired in 2024 as R&D Vice President and was honoured as a member of P&G\u2019s Victor Mills Society, the company\u2019s most prestigious recognition for scientific innovation.<\/p>\n

\nA global authority on human skin optics, stratum corneum biology, sun protection and the psychology of skin perception, Dr. Matts has authored over 65 peer-reviewed publications, delivered more than 150 keynote presentations worldwide and is widely recognized as a leader in both dermatology and cosmetic science. His pioneering work on MedX\u2019s technology, Spectrophotometric Intracutaneous Analysis (SIAscopy\u00ae) enabled, for the first time, the simultaneous, non-invasive measurement of melanin, hemoglobin and collagen, driving powerful new application in both the early detection of malignant melanoma skin cancer and the cosmetic sciences.<\/p>\n

\nDr. Matts has been a leader in the development of standardized global test methods for sun protection since 1993, at European Trade Association level (as the Chairman of the Cosmetics Europe (CE) Sun Protection Methods Task Force and then the Chairman of the CE Sun Protection Strategic Advisory Group) and at International Standards Organisation level (as the UK expert to the ISOTC217\/WG5 working group, that has now developed and deployed 4 new SPF and UVA international standards). He is also an elected Fellow of the Royal Society of Chemistry and the Royal Society of the Arts, reflecting his leadership at the intersection of science, technology and public benefit.<\/p>\n

\nPassionate about education, Dr. Matts has been a Lecturer for the London College of Fashion\u2019s Cosmetic Science Degree and Masters courses since 1993, was appointed Visiting Professor to the UCL School of Pharmacy in 2007 and Visiting Professor to the London College of Fashion in 2010. In 2013, Dr. Matts established the annual P&G Better Lives Awards, recognising and supporting outstanding students across the London College of Fashion. In July 2025, Dr. Matts was recognized with an Honorary Doctorate by the University of the Arts London.<\/p>\n

\nBeyond his academic and industry leadership, Dr. Matts co-founded \u201cAction on Podo\u201d in 2012, a registered Ethiopian non-governmental organization dedicated to eradicating podoconiosis, a devastating, preventable skin disease afflicting over 1.5 million people. Under his leadership, the on-going initiative has now successfully treated more than 40,000 patients.<\/p>\n

\n\u201cMedX is advancing the early detection of skin cancer at scale using its DermSecure\u00ae platform, coupled with MedX\u2019s imaging technology (SIAcopy\u00ae),\u201d said Dr. Matts. \u201cI am delighted to contribute my experience in skin optics, sun protection and perception science to help accelerate MedX\u2019s mission to reduce the global burden of skin cancer and preventable skin disease.\u201d<\/p>\n

\nJohn Gevisser, CEO of MedX Health, added: \u201cDr. Paul Matts is not only one of the world\u2019s foremost authorities on skin science and sun protection, but also an educator and humanitarian who has dedicated his career to improving the lives of others. His expertise will strengthen MedX\u2019s scientific foundation and help advance our goal of delivering accurate, trusted and widely-accessible skin cancer screening and the development of new skin assessment technologies for the health and beauty industry.\u201d<\/p>\n

\nAbout MedX Health Corp.:<\/b><\/p>\n

\nMedX Health Corp., headquartered in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. Its proprietary SIAscopy\u00ae technology, integrated into the DermSecure\u00ae platform, enables pain-free, accurate imaging of skin lesions for rapid dermatologist review. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformit\u00e9 Europ\u00e9enne, for use in Canada, the U.S., Australia, New Zealand, the United Kingdom, the European Union and Turkey. MedX\u2019s advanced telemedicine platform enables healthcare professionals to quickly and accurately assess suspicious moles, lesions, and other skin conditions through its proprietary imaging technology, SIAscopy\u00ae<\/b>, and its secure, cloud-based patient management system, DermSecure\u00ae<\/b>. SIAscopy\u00ae is the only technology capable of the simultaneous, non-invasive measurement of the concentration and spatial distribution of melanin, hemoglobin and collagen in the epidermis and dermis of human skin. Visit: https\/\/www.medxhealth.com<\/a><\/p>\n

\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i><\/b><\/p>\n

\nThis Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.<\/i><\/b><\/p>\n

Contacts<\/b> <\/p>\n

\nMedX Health Corp.
\n
John Gevisser, CEO- MedX Health Corp.
\n
john.gevisser@medxhealth.com<\/a>
(+1) 905-670-4428<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (TSXV: MDX), \u201cMedX\u201d or the \u201cCompany\u201d), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company. Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61834","6":"format-standard","7":"category-industry"},"yoast_head":"\nMedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (TSXV: MDX), \u201cMedX\u201d or the \u201cCompany\u201d), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company. Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-09T02:06:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250908353613\/en\/618221\/22\/MedX_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor\",\"datePublished\":\"2025-09-09T02:06:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/\"},\"wordCount\":861,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250908353613\\\/en\\\/618221\\\/22\\\/MedX_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/\",\"name\":\"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250908353613\\\/en\\\/618221\\\/22\\\/MedX_Logo.jpg\",\"datePublished\":\"2025-09-09T02:06:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250908353613\\\/en\\\/618221\\\/22\\\/MedX_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250908353613\\\/en\\\/618221\\\/22\\\/MedX_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/","og_locale":"en_US","og_type":"article","og_title":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Pharma Trend","og_description":"MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (TSXV: MDX), \u201cMedX\u201d or the \u201cCompany\u201d), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company. Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-09T02:06:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250908353613\/en\/618221\/22\/MedX_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor","datePublished":"2025-09-09T02:06:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/"},"wordCount":861,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250908353613\/en\/618221\/22\/MedX_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/","url":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/","name":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250908353613\/en\/618221\/22\/MedX_Logo.jpg","datePublished":"2025-09-09T02:06:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250908353613\/en\/618221\/22\/MedX_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250908353613\/en\/618221\/22\/MedX_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61834"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61834\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}